CANAKINUMAB PRE-FILLED SYRINGE VS TRIAMCINOLONE ACETONIDE IN THE TREATMENT OF ACUTE GOUTY ARTHRITIS ATTACKS: RESULTS FROM A POST-HOC ANALYSIS IN DIFFICULT-TO-TREAT PATIENTS

被引：0
|
作者：
Sunkureddi, P. [1 ]
Toth, E. [2 ]
Brown, J. [3 ,4 ]
Kivitz, A. [5 ]
Stancati, A. [6 ]
Richard, D. [6 ]
Lheritier, K. [6 ]
Moericke, R. [7 ]
机构：
[1] Clear Lake Rheumatol, Houston, TX USA
[2] Flor Francis Hosp, Rheumatol Dept, Kistarcsa, Hungary
[3] CHU Quebec Res Ctr, Quebec City, PQ, Canada
[4] Univ Laval, Quebec City, PQ, Canada
[5] Altoona Ctr Clin Res, Duncansville, PA USA
[6] Novartis Pharma AG, Basel, Switzerland
[7] Inst Pravent Med & Klin Forsch GbR, Magdeburg, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1846
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0848
引用
收藏
页码：1083 / 1083
页数：1
相关论文
共 16 条
  • [1] Efficacy and Safety Of Canakinumab Pre-Filled Syringe Versus Triamcinolone Acetonide In Acute Gouty Arthritis Patients
    Sunkureddi, Prashanth
    Toth, Edith
    Brown, Jacques P.
    Moericke, Ruediger
    Nebesky, Jan Michael
    Krammer, Gerhard
    Tao, Aiyang
    John, Markus
    Kivitz, Alan
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S498 - S498
  • [2] CANAKINUMAB VS TRIAMCINOLONE ACETONIDE FOR TREATMENT OF ACUTE FLARES AND PREVENTION OF RECURRENT FLARES IN "DIFFICULT TO TREAT" GOUTY ARTHRITIS
    Schlesinger, N.
    De Meulemeester, M.
    Shamim, T.
    Pikhlak, A.
    Arulmani, U.
    Richard, D.
    Murphy, V
    Sallstig, P.
    So, A.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S23 - S23
  • [3] CANAKINUMAB (ACZ885) RELIEVES PAIN AND CONTROLS INFLAMMATION RAPIDLY IN PATIENTS WITH DIFFICULT-TO-TREAT GOUTY ARTHRITIS: COMPARISON WITH TRIAMCINOLONE ACETONIDE
    So, Alexander
    De Meulemeester, M.
    Pikhlak, A.
    Yucel, A. E.
    Bodalia, B.
    Kerrane, J.
    Arulmani, U.
    Richard, D.
    Murphy, V.
    Sallstig, P.
    Schlesinger, N.
    RHEUMATOLOGY, 2011, 50 : 32 - 32
  • [4] EFFICACY AND SAFETY OF CANAKINUMAB PRE-FILLED SYRINGE IN ACUTE GOUTY ARTHRITIS PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE ≥3
    Sunkureddi, P.
    Toth, E.
    Brown, J.
    Kivitz, A.
    Stancati, A.
    Richard, D.
    Lheritier, K.
    Moericke, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1083 - 1083
  • [5] Canakinumab for the Treatment of Acute Flares in Difficult-to-Treat Gouty Arthritis Results of a Multicenter, Phase II, Dose-Ranging Study
    So, Alexander
    De Meulemeester, Marc
    Pikhlak, Andrey
    Yucel, A. Eftal
    Richard, Dominik
    Murphy, Valda
    Arulmani, Udayasankar
    Sallstig, Peter
    Schlesinger, Naomi
    ARTHRITIS AND RHEUMATISM, 2010, 62 (10): : 3064 - 3076
  • [6] LONG-TERM SAFETY AND EFFICACY OF CANAKINUMAB VS TRIAMCINOLONE ACETONIDE IN PATIENTS WITH FREQUENT ACUTE GOUTY ARTHRITIS ATTACKS WHO ARE CONTRAINDICATED, INTOLERANT OR UNRESPONSIVE TO NSAIDS AND/OR COLCHICINE
    Alten, R.
    Schlesinger, N.
    So, A.
    Schumacher, H. R.
    Bloch, M. T.
    Machein, U.
    Richard, D.
    Lheritier, K.
    Bardin, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 785 - 785
  • [7] BURDEN OF REFRACTORY GOUTY ARTHRITIS AMONG DIFFICULT-TO-TREAT PATIENTS OVER ONE YEAR: POST- HOC ANALYSIS FROM MOTION OBSERVATIONAL STUDY
    Bessette, L.
    Liote, F.
    Moragues, C.
    Moericke, R.
    Zhang, Z.
    Ferreira, A.
    Lecomte, P.
    Kessabi, S.
    Tian, H.
    Li, L.
    Singh, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1154 - 1155
  • [8] CANAKINUMAB (ACZ885) VS TRIAMCINOLONE ACETONIDE FOR TREATMENT OF ACUTE FLARES AND PREVENTION OF RECURRENT FLARES IN GOUTY ARTHRITIS PATIENTS REFRACTORY TO OR CONTRAINDICATED TO NSAIDS AND/OR COLCHICINE
    So, Alexander
    Meulemeester, Marc D.
    Bodalia, Bhavesh
    Shamim, Talha
    Pikhlak, Andrey
    Yucel, A. Eftal
    Arulmani, Udayasankar
    Richard, Dominik
    Murphy, Valda
    Sallstig, Peter
    Schlesinger, Naomi
    RHEUMATOLOGY, 2010, 49 : I60 - I61
  • [9] A controlled trial of canakinumab vs triamcinolone acetonide in acute gouty arthritis patients: Results of the β-relieved study (response in acute flare and in prevention of episodes of re-flare in gout)
    So, A.
    Alten, R.
    Bardin, T.
    Bloch, M.
    Schumacher, H. R.
    Rolfe, A.
    Murphy, V.
    Sallstig, P.
    Richard, D.
    Gimona, A.
    Schlesinger, N.
    SWISS MEDICAL WEEKLY, 2011, 141 : S3 - S3
  • [10] Canakinumab In The Treatment Of Systemic Juvenile Idiopathic Arthritis: Results From a 12-Week Pooled Post-Hoc Analysis For Efficacy
    Brunner, Hermine
    Quartier, Pierre
    Constantin, Tamas
    Padeh, Shai
    Calvo, Inmaculada
    Erguven, Muferet
    Goffin, Laurence
    Hofer, Michael
    Kallinich, Tilmann
    Oliveira, Sheila
    Uziel, Yosef
    Viola, Stefania
    Nistala, Kiran
    Wouters, Carine
    Lheritier, Karine
    Hruska, Josef
    Abrams, Ken
    Martini, Alberto
    Ruperto, Nicolino
    Lovell, Daniel J.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S112 - S113
12